Completed OBSERVATIONAL NCT02965560

Exploring Biomarkers Predicting the Outcome of Acute-on-chronic Liver Failure (PGE2)

A Study on Biomarkers Predicting the Outcome of Acute-on-chronic Liver Failure

Sponsor: First Affiliated Hospital of Zhejiang University

Conditions Acute-On-Chronic Liver Failure Cirrhosis and Chronic Liver Disease

Interventions plasma suPAR, PGE2 measurement. Other biomarkers were just recorded from clinical laboratory.

Updated 7 times since 2017 Last updated: Jun 3, 2018 Started: Oct 10, 2016 Primary completion: Oct 10, 2017 Completion: Jun 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Acute-On-Chronic Liver Failure and Cirrhosis and Chronic Liver Disease and is currently completed. First Affiliated Hospital of Zhejiang University leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jul 2018 — Jan 2021 [monthly]

Completed

Status: Not Yet Recruiting → Completed
Jun 2018 — Jul 2018 [monthly]

Not Yet Recruiting

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Not Yet Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Not Yet Recruiting NA

First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

First Affiliated Hospital of Zhejiang University

Data source: First Affiliated Hospital of Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.